Literature DB >> 32281948

Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses.

Allen C Steere.   

Abstract

Mesh：

Year:  2020        PMID： 32281948      PMCID： PMC7190968          DOI： 10.1172/JCI138062

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  28 in total

Review 1.  Post-treatment lyme syndrome and central sensitization.

Authors:  Shweta Batheja; Jenifer A Nields; Alla Landa; Brian A Fallon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2013       Impact factor: 2.198

2.  Robust interferon signature and suppressed tissue repair gene expression in synovial tissue from patients with postinfectious, Borrelia burgdorferi-induced Lyme arthritis.

Authors:  Robert B Lochhead; Sheila L Arvikar; John M Aversa; Ruslan I Sadreyev; Klemen Strle; Allen C Steere
Journal:  Cell Microbiol       Date:  2018-10-17       Impact factor: 3.715

3.  Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis.

Authors:  Jameson T Crowley; Klemen Strle; Elise E Drouin; Annalisa Pianta; Sheila L Arvikar; Qi Wang; Catherine E Costello; Allen C Steere
Journal:  J Autoimmun       Date:  2016-02-26       Impact factor: 7.094

4.  Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis.

Authors:  Xin Li; Gail A McHugh; Nitin Damle; Vijay K Sikand; Lisa Glickstein; Allen C Steere
Journal:  Arthritis Rheum       Date:  2011-08

5.  Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.

Authors:  Adriana Marques; Sam R Telford; Siu-Ping Turk; Erin Chung; Carla Williams; Kenneth Dardick; Peter J Krause; Christina Brandeburg; Christopher D Crowder; Heather E Carolan; Mark W Eshoo; Pamela A Shaw; Linden T Hu
Journal:  Clin Infect Dis       Date:  2014-02-11       Impact factor: 9.079

6.  HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis.

Authors:  Bettina Panagiota Iliopoulou; Mireia Guerau-de-Arellano; Brigitte T Huber
Journal:  Arthritis Rheum       Date:  2009-12

7.  A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.

Authors:  B A Fallon; J G Keilp; K M Corbera; E Petkova; C B Britton; E Dwyer; I Slavov; J Cheng; J Dobkin; D R Nelson; H A Sackeim
Journal:  Neurology       Date:  2007-10-10       Impact factor: 9.910

8.  Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.

Authors:  L B Krupp; L G Hyman; R Grimson; P K Coyle; P Melville; S Ahnn; R Dattwyler; B Chandler
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

9.  Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.

Authors:  Monica E Embers; Stephen W Barthold; Juan T Borda; Lisa Bowers; Lara Doyle; Emir Hodzic; Mary B Jacobs; Nicole R Hasenkampf; Dale S Martin; Sukanya Narasimhan; Kathrine M Phillippi-Falkenstein; Jeanette E Purcell; Marion S Ratterree; Mario T Philipp
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

10.  Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis.

Authors:  Brandon L Jutras; Robert B Lochhead; Zachary A Kloos; Jacob Biboy; Klemen Strle; Carmen J Booth; Sander K Govers; Joe Gray; Peter Schumann; Waldemar Vollmer; Linda K Bockenstedt; Allen C Steere; Christine Jacobs-Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-17       Impact factor: 11.205
View more
  7 in total

Review 1.  A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist.

Authors:  Katelyn H Wong; Eugene D Shapiro; Gary K Soffer
Journal:  Clin Rev Allergy Immunol       Date:  2021-10-23       Impact factor: 8.667

Review 2.  Lyme Arthritis.

Authors:  Sheila L Arvikar; Allen C Steere
Journal:  Infect Dis Clin North Am       Date:  2022-09       Impact factor: 5.905

3.  Lyme Disease in Humans.

Authors:  Justin D Radolf; Klemen Strle; Jacob E Lemieux; Franc Strle
Journal:  Curr Issues Mol Biol       Date:  2020-12-11       Impact factor: 2.081

4.  The peptidoglycan-associated protein NapA plays an important role in the envelope integrity and in the pathogenesis of the lyme disease spirochete.

Authors:  Marisela M Davis; Aaron M Brock; Tanner G DeHart; Brittany P Boribong; Katherine Lee; Mecaila E McClune; Yunjie Chang; Nicholas Cramer; Jun Liu; Caroline N Jones; Brandon L Jutras
Journal:  PLoS Pathog       Date:  2021-05-13       Impact factor: 6.823

Review 5.  Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes.

Authors:  Felipe C Cabello; Monica E Embers; Stuart A Newman; Henry P Godfrey
Journal:  mBio       Date:  2022-04-25       Impact factor: 7.786

6.  Predicting Lyme Disease From Patients' Peripheral Blood Mononuclear Cells Profiled With RNA-Sequencing.

Authors:  Daniel J B Clarke; Alison W Rebman; Allison Bailey; Megan L Wojciechowicz; Sherry L Jenkins; John E Evangelista; Matteo Danieletto; Jinshui Fan; Mark W Eshoo; Michael R Mosel; William Robinson; Nitya Ramadoss; Jason Bobe; Mark J Soloski; John N Aucott; Avi Ma'ayan
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

Review 7.  Lyme arthritis: linking infection, inflammation and autoimmunity.

Authors:  Robert B Lochhead; Klemen Strle; Sheila L Arvikar; Janis J Weis; Allen C Steere
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 32.286
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.